OCS
Price
$18.07
Change
-$0.13 (-0.71%)
Updated
Aug 8, 10:30 AM (EDT)
Capitalization
928.81M
SNSE
Price
$7.20
Change
-$0.01 (-0.14%)
Updated
Aug 8, 10:39 AM (EDT)
Capitalization
9.09M
Interact to see
Advertisement

OCS vs SNSE

Header iconOCS vs SNSE Comparison
Open Charts OCS vs SNSEBanner chart's image
Oculis Holding AG
Price$18.07
Change-$0.13 (-0.71%)
VolumeN/A
Capitalization928.81M
Sensei Biotherapeutics
Price$7.20
Change-$0.01 (-0.14%)
Volume$1.09K
Capitalization9.09M
OCS vs SNSE Comparison Chart in %
Loading...
OCS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNSE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
OCS vs. SNSE commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OCS is a Buy and SNSE is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (OCS: $18.20 vs. SNSE: $7.21)
Brand notoriety: OCS and SNSE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: OCS: 26% vs. SNSE: 36%
Market capitalization -- OCS: $928.81M vs. SNSE: $9.09M
OCS [@Biotechnology] is valued at $928.81M. SNSE’s [@Biotechnology] market capitalization is $9.09M. The market cap for tickers in the [@Biotechnology] industry ranges from $199.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OCS’s FA Score shows that 0 FA rating(s) are green whileSNSE’s FA Score has 1 green FA rating(s).

  • OCS’s FA Score: 0 green, 5 red.
  • SNSE’s FA Score: 1 green, 4 red.
According to our system of comparison, SNSE is a better buy in the long-term than OCS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OCS’s TA Score shows that 6 TA indicator(s) are bullish while SNSE’s TA Score has 5 bullish TA indicator(s).

  • OCS’s TA Score: 6 bullish, 4 bearish.
  • SNSE’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, OCS is a better buy in the short-term than SNSE.

Price Growth

OCS (@Biotechnology) experienced а +3.17% price change this week, while SNSE (@Biotechnology) price change was -3.61% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.18%. For the same industry, the average monthly price growth was +8.39%, and the average quarterly price growth was +12.02%.

Industries' Descriptions

@Biotechnology (+1.18% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OCS($929M) has a higher market cap than SNSE($9.09M). OCS YTD gains are higher at: 7.059 vs. SNSE (-26.444). SNSE has higher annual earnings (EBITDA): -27.93M vs. OCS (-101.78M). OCS has less debt than SNSE: OCS (1.1M) vs SNSE (3.21M). OCS (0) and SNSE (0) have equivalent revenues.
OCSSNSEOCS / SNSE
Capitalization929M9.09M10,222%
EBITDA-101.78M-27.93M364%
Gain YTD7.059-26.444-27%
P/E Ratio63.08N/A-
Revenue00-
Total Cash182MN/A-
Total Debt1.1M3.21M34%
TECHNICAL ANALYSIS
Technical Analysis
OCSSNSE
RSI
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
51%
Bullish Trend 1 day ago
85%
Momentum
ODDS (%)
Bullish Trend 1 day ago
51%
Bullish Trend 1 day ago
80%
MACD
ODDS (%)
Bullish Trend 1 day ago
65%
Bullish Trend 1 day ago
75%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
50%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
49%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 5 days ago
71%
Bullish Trend 8 days ago
76%
Declines
ODDS (%)
Bearish Trend 9 days ago
63%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
60%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
45%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
OCS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNSE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ILAG0.530.01
+2.50%
Intelligent Living Application Group
EG328.15-0.34
-0.10%
Everest Group Ltd
HELE21.99-0.23
-1.04%
Helen of Troy Limited
DNTH19.15-1.24
-6.08%
Dianthus Therapeutics
GAUZ6.17-0.43
-6.52%
Gauzy Ltd

OCS and

Correlation & Price change

A.I.dvisor indicates that over the last year, OCS has been loosely correlated with CUE. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if OCS jumps, then CUE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OCS
1D Price
Change %
OCS100%
N/A
CUE - OCS
35%
Loosely correlated
+3.45%
SNSE - OCS
32%
Poorly correlated
-6.97%
PRAX - OCS
29%
Poorly correlated
-2.74%
CGEN - OCS
29%
Poorly correlated
-1.37%
GRI - OCS
28%
Poorly correlated
-0.80%
More

SNSE and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNSE has been loosely correlated with VSTM. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if SNSE jumps, then VSTM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNSE
1D Price
Change %
SNSE100%
-6.97%
VSTM - SNSE
47%
Loosely correlated
-5.86%
ALZN - SNSE
40%
Loosely correlated
-1.10%
GRI - SNSE
39%
Loosely correlated
-0.80%
MOLN - SNSE
38%
Loosely correlated
+5.32%
INAB - SNSE
37%
Loosely correlated
+2.38%
More